ABSTRACT
INTRODUCTION
It is well recognized that metastases to the skeleton is by far the most common type of malignant bone tumors. [1] Evidence of osseous metastasis is of clinical importance because it is essential for clinical staging and the subsequent therapy planning. Localization and spreading of the skeletal metastasis must be displayed to identify possibly threatening complications in a timely manner. [2] Metastasis of the bones tends to occur in areas of the red bone marrow with good vascularization, which, therefore, explains the tendency of metastases to be localized in the axial skeleton(80% ), the femur (40%) as well as the skull and the pelvis (20%). Additional areas of manifestation are the ribs and the sternum (25-30%). [3] All existing methods of detecting skeletal metastases have certain limitations as discussed earlier in our study based on either the nature of the metastatic lesions (Lytic, sclerotic or mixed) or the distribution with certain blind spots encountered in each modality or severity of lesion (early or established with a spectrum of changes in between). Tc-phosphonate based skeletal scintigraphy has been the standard method for the initial staging of bone metastases. However, it depicts bone metastases at a relatively advanced stage of tumor infiltration when osteoblastic host reaction to tumor deposits has already occurred rendering it a fertile environment for a vast number of studies attempting to assess different parameters as conspicuity of lesions and the capability of different modalities to accurately characterize the lesions. MRI has been verified to assess bone marrow metastases at significantly earlier stages than skeletal scintigraphy, yet due to the long examination time and the high cost, MRI has not been able to be widely applied as the routine method for the screening of the entire skeletal system, it has been confined to regional assessments based on equivocal findings on other imaging modalities or persistence of patient's symptoms despite negative findings on other modalities. Furthermore, there are technical limitations exists which have hampered fast MR imaging. [4] New developments in gradient echo technology and new patient table and coil concepts have made MRI a method to be considered for the evaluation of tumor patients. [5] Based on our results from the examination of 60 patients, whole-body MRI using T1W, STIR & diffusion sequences through a moving tabletop and tabletop extender where patients were placed supine head first and were examined using the integrated body coil and an additional 32 channel phased array torso coil to improve signal arising from the chest and upper abdomen together with using a circularly polarized spine coil to receive high resolution spine images is a fast, dependable alternative to skeletal scintigraphy for the detection of metastases of the skeletal system. Several studies have compared skeletal scintigraphy and WB-MRI reporting different sensitivities and specificities. Other studies tackled the additional role of DWI in further detection and characterization of skeletal lesions compared to established conventional MR sequences. In our study we integrated both aspects WB-MRI compared to bone scan and the role of WB-DWI; the extra 25-30 minutes lengthening of the study, is it worth it? PATIENTS AND METHODS 60 patients comprising 38 females and 22 males ranging in age from 30 to 60 years with a mean age of 48.1 years (mean age 47.3 years for females and 49 years for males) were enrolled in the study. 29 females are histopathologically proven cases of breast malignancy, 9 females and the 22 males are histopathologically proven cases of lung cancer. The patients were referred from Oncological departments to perform the whole body MR study and bone scan at Ain Shams University hospitals MRI units and a private center during the time interval from December 2008 till December 2012.
The inclusion criteria were: Age group: 30 to 60 years, both sexes are included, patients with histopathologically proven breast and lung cancer and current complaint of bone aches. The exclusion criteria were: Children and elderly patients, lactating and pregnant females and patients known to have end stage renal disease.
Bone scan imaging protocol:
-Patients were informed to be well hydrated. -Patients were asked to void immediately prior to study and frequently after the injection of the radiotracer administration throughout the day. -Patients were asked to remove metal objects before imaging (e.g: watches, keys, jewelry, coins. etc) -A 20 mCi (70 MBq) bolus of Tc-99m
MDP is injected intravenously. -Imaging was commenced 2-4 hours after tracer administration. -Anterior and Posterior images of the whole skeleton were taken at counts/image. -Variable spot views were taken differing from one patient to another (300k-500k counts/image).
MR imaging protocol:
Whole body MR studies were performed on 1.5-T superconducting magnet (Achieva; Phillips Medical Systems) by using a moving tabletop and tabletop extender. The patients were placed supine head first and were examined using the integrated body coil and an additional 32 channel phased array torso coil to improve signal arising from the chest and upper abdomen. Images of the spine were acquired using a circularly polarized spine coil. Slice orientation was coronal for the trunk and extremities and sagittal for the spine. The entire MR imaging procedure took 60-90 min. The following protocol was used for all patients, except for twelve patients who weren't administered IV contrast: 1) The parameters for the whole body coronal T1-weighted sequence were  as follows:  single-shot turbo spin echo; TR/TE,  537/ Applied parameters for the whole spine sagittal T1W sequence were as follows: turbo spin-echo images; TR/TE, 180/10; bandwidth, 195 Hz/pixel; number of slices, 11; section thickness, 4 mm; intersection gap, 0.8 mm; echo train length, three; refocusing flip angle, 180°; field of view, 380 × 380 cm; matrix, 177 × 256; are acquired at two stations (cervicodorsal and dorsolumbar regions) and are composed into single images through computed alignment. The total imaging time for both stations is 2 minutes 12 seconds. 4) Applied parameters for the whole spine sagittal STIR sequence were as follows: TR/TE, 4500/101; bandwidth, 252 Hz/pixel; acceleration factor, 2; number of sections, 11; section thickness, 4 mm; echo train length, 29; refocusing flip angle, 150°; field of view, 380 × 380 cm; matrix, 320 × 320; are acquired at two stations (cervicodorsal and dorsolumbar regions) and are composed into single images by computed alignment. The total imaging time for both stations is 2 minutes 36 seconds. Tc-MDP on skeletal scintigraphy that could not be definitely explained by benign abnormalities, e.g. degenerative joint disease, secondary changes to fractures were considered to be suspected metastases. A patient was considered to have negative imaging findings when no bony lesions meeting the criteria of malignancy were identified. Findings of the whole-body MRI and the skeletal scintigram were compared to the "gold standard" which was either biopsy and histopathological verification (not feasible for all lesions) or follow up (at a 3-6 month interval).
Another parameter was assessed which is Conspicuity and contrast-to-noise ratio to analyse and compare the different MR sequences (T1W, STIR and DWI): The MR imaging sequences were compared qualitatively by ordering the sequences according to the conspicuity of the bone metastases and semiquantitatively in terms of contrast-to-noise ratio (CNR). CNRs were computed according to the following formula: CNR = (SImet − SIbone)/N, with SImet and SIbone defined as mean signal intensity inside the ROI placed on the metastasis and normal bone, respectively, and N defined as noise signifying the standard deviation inside the ROI placed outside the body. Soft tissue lesions detected on MRI were compared in terms of detection and characterization before and after adding DWI.
Statistical analysis:
Sensitivity, specificity, PPV and NPV were calculated for lesion detection and characterization by bone scan, WB-MRI with and without diffusion and compared. The CNRs were compared with a general linear model with repeated measures. The effect of the innersubject factor was tested by using a difference with P < .05 as significant. Calculations were performed by using a statistical software package (JMP 7.0.2, 2008)/McNemar test.
RESULTS
Our study included 60 patients comprising 38 females and 22 males ranging in age from 30 to 60 years with a mean age of 48.1 years (mean age 47.3 years for females and 49 years for males). 29 females are histopathologically proven cases of breast malignancy, 9 females and the 22 males are histopathologically proven cases of lung cancer as demonstrated in table (1) . Table ( 1): Distribution of the sixty patients in the different age groups. All the patients were subjected to a whole body MR study including coronal T1W, STIR and DWIBS sequences, axial DWIs were acquired for the purpose of quantification (generating ADC maps), sagittal T1W and STIR images of the whole spine together with a post contrast study within 72 hours to a maximum of one week from scintigraphic bone scan during the time interval from December 2008 till December 2012. Twelve cases out of sixty refused contrast as they couldn't tolerate the length of the study with their bone aches and they refused sedation.
The cases came presented primarily with regional bone aches, (some had accentuated regional bone aches on top of generalized bone aches) and other symptoms variably encountered including dyspnea , jaundice, disturbed consciousness level and /or other neurological manifestations. The 29 breast cases enrolled in the study were in either of the following stages of management: 1)
Recent diagnosis prior to commencement of therapy: 14 cases.
2) After surgery prior to commencement of CTH or RTH: 11 cases. 3) On CTH and RTH after surgery: 2 cases. 4) On hormonal therapy after stoppage of post surgical CTH and RTH: 2 cases. 5) On neoadjuvant CTH in a case of advanced breast malignancy: 1 case. The 31 lung cases enrolled in the study were in either of the following stages of management: 1) On CTH and RTH without surgery: 15 cases.
2)
Recent diagnosis prior to commencement of therapy: 10 cases.
3) On CTH after surgery: 6 cases. The results of bone scans and whole body MR studies were either verified by follow up or by biopsy where 25 lesions were biopsied in 22 patients (14 breast cases and 8 lung cases) and the rest were followed up.
BONE SCAN RESULTS:
A total of 158 lesions were reported on bone scans, 71 lesions were vertebral, 43 lesions were pelvic, 21 lesions were thoracic, 16 lesions were in the appendicular skeleton and 7 were calvarial as plotted in the graph showing the abundance of vertebral lesions. The lesions reported with confidence as metastatic included 59 vertebral lesions, 22 pelvic lesions, 15 thoracic lesions, 8 appendicular lesions and 7 calvarial lesions showing the prevalence of confidently detected vertebral lesions. As for the equivocal lesions, they were predominantly seen along the appendicular skeleton falling in the differential diagnosis of metastases, assymetric patchy marrow hyperplasia and osteonecrosis. Based on our study, the highest degrees of confidence in the detection of metastatic osseous lesions were encountered with thoracic metastasis followed by calvarial and vertebral metastases, while the least confidence and accordingly the more equivocal lesions were met with as regards the pelvic and appendicular lesions. Out of these 111 confidently diagnosed metastatic lesions, 19 turned out to be false positive with a distribution as displayed in the pie chart (11 lesions confirmed by biopsy , 5 by disappearance/ appearing stationary without treatment on follow up studies and 3 confirmed not malignant on other imaging modalities). There were 22 mismatched lesions between bone scan and MRI that were not seen on bone scan, 15 lesions were confirmed malignant; 6 through biopsy and histopathological verification and 9 through progression on follow up. The majority of those 15 false negative lesions on bone scan were appendicular followed by pelvic lesions as plotted on the pie chart with a distribution of 4 The forementioned results are representing one sector of the study which is considered the main sector, but then there is another parallel sector of major influence on patient's management and therapeutic planning which is related to the detection and verification of soft tissue metastatic involvement and comparing results of MRI with and without DWI. Conventional MR images revealed: 1) 23 hepatic focal lesions in 14 cases.
2) 19 lymph nodes suggested to be metastatic, 11 were axillary in 7 breast cases and 8 were hilar/mediastinal in 4 lung cases. 3) 9 suggested adrenal metastases in 7 cases of lung cancer with a confidence in diagnosing 7 of these lesions.
4)
2 cases were suggested to have leptomeningeal infiltrates, one spinal and one intracranial with the latter being merely conspicuous. 5) 1 case of breast cancer showed renal metastasis. 6) 2 cases showed lesions suggested to be intramuscular soft tissue metastatic deposits, two at left calf muscles in one case and one at medial muscular compartment of the left thigh in another patient. 7) 5 cases of breast cancer and 4 cases of lung cancer showed pulmonary nodules (about 16) suggested to be metastatic. 8) 5 cases (3 breast cases and 2 lung cases) showed uneven pleural thickening, 3 of which were suspicious of a metastatic nature and 2 were suggested to be benign post irradiation pleural thickenings. 9) 12 cases showed 18 brain lesions best demonstrated on post contrast images with about 12 being confidently diagnosed as metastatic. On adding diffusion to conventional MR images, it had the following influence on the detection and characterization of soft tissue lesions: 1) -31 hepatic focal lesions in 16 cases, 11 were breast cases and 5 were lung cases. 2) -22 lymph nodes suggested to be metastatic, 12 were axillary and 1 supraclavicular in 7 breast cases and 9 were hilar/mediastinal in 6 lung cases. 3) 10 suggested adrenal metastases in 7 cases of lung cancer with a confidence in diagnosing 9 of these lesions. 4) 3 cases were confidently called leptomeningeal infiltrates, one spinal and two intracranial (one of which was merely conspicuous on conventional MR images). 5) 1 case of breast cancer with renal metastasis. 6) The 3 intramuscular soft tissue lesions that were seen on conventional MRI; the two left calf lesions still remained equivocal due to the overlap in ADC values between a chronic hematoma and a soft tissue. 7) 6 cases of breast cancer and 4 cases of lung cancer showed 23 pulmonary nodules. 8) 7 cases (5 breast cases and 2 lung cases) showed uneven pleural thickening, 3 were suggested metastatic appearing as an irregular hypointense rim on corresponding ADC maps giving a low mean ADC value. 9) The 12 lesions reported metastatic out of the 18 brain lesions on conventional MRI were supported metastatic on DWI. The majority of soft tissue lesions were verified on follow up and only the left calf intramuscular lesions, the left renal metastasis and an adrenal metastasis were verified by biopsies.
WB-MRI with diffusion came superior to WB-MRI without diffusion in the detection of: 1)8 extra hepatic focal lesions (6 metastatic) and adding 2 more patients. 2)3 extra metastatic lymph nodes. 3)1 extra adrenal metastasis in a case with no other soft tissue metastases. 4)1 extra leptomeningeal metastasis and an extra case was added. 5)7 extra pulmonary nodules. 6)2 extra cases with pleural thickenings. Although DWI showed a high sensitivity (94% & 86%) in the detection of lymph nodes and pulmonary nodules respectively yet it showed a low specificity (55% & 52%) in the differentiation between benign and malignant lymph nodes and pulmonary nodules respectively. Two of the confidently called metastatic pleural thickenings on MRI with and without diffusion turned out to be false positive and suggested to be post irradiation fibrosis based on a one year follow up stationary course. This is an example of a case show osseous and soft tissue metastatic lesions; a 42 -year-old female patient with recently diagnosed breast cancer was presented with lower back pain, right sciatica. Her bone scan revealed osseous metastases at D1 and L2. On correlation with her WB-MRI, it showed osseous metastases at C5, D1 and L2. The L2 vertebral lesion showed an extra-osseous soft tissue component intra and retrospinal compromising L2/L3 neural foramen, implicating right L3 nerve root. Her MR study more so her DWI showed 2 metastatic pulmonary nodules as demonstrated in figures (1) and (2). -3 mm 2 /sec. In this case we can see that bone scan detected a sternal metastasis not conspicuous on MRI confirmed on follow up and the WB-MRI with diffusion showed a small lesion at C5 vertebra, a soft tissue component in association with the L2 lesion implicating right L3 nerve root and two pulmonary metastatic nodules.
DISCUSSION
Based on our study, the confidence of detection and characterization of skeletal metastases on bone scan was scaled as thoracic including rib and sternal lesions being the highest (93.7%) with the least percent of equivocal lesions (5.2%), followed by vertebral and calvarial lesions (86% & 87.5% respectively) with a percent of equivocal lesions (12.6% & 12.5% respectively), then we have pelvic lesions (72.7%) with a percent of equivocal lesions (26%) and last we have the appendicular lesions (57%) with a percent of equivocal lesions (35.4%).
According to this, we are proposing that skeletal scintigraphy is much better established for the detection and characterization of thoracic lesions followed by vertebral and calvarial lesions all the way down to appendicular lesions where bone scan wouldn't be the study of choice when it comes to decision making in patient management. Another study addressing the accuracy of bone scan, concluded that it had a sensitivity of 88.4% in vertebral lesions, 74% in pelvic lesions, 66.9% in calvarial lesions, 61% in thoracic lesions and 48% in appendicular lesions. [5] Ryoto et al's results were comparable to our study concluding that bone scan had a high diagnostic accuracy in vertebral and calvarial lesions followed by thoracic and pelvic lesions and last in long bones. [6] One of these cases that had false positive lesions was rather interesting having a rare autosomal dominant bone disorder known as Osteopoikilosis where the bone scan showed hot foci at the left femoral head, the corresponding MR study showed multiple rounded sclerotic bone lesions of more or less the same size at both hip joint regions (acetabular bones and femoral heads) appearing hypointense on T1W images, hardly conspicuous on STIR showing no diffusion restriction as seen in figure (3) .
What was interesting in this case was that the patient was complaining of persistent back pain and was a recently diagnosed case of lung cancer. His bone scan came negative for any vertebral metastases while his MR study showed a lumbar lesion that was called metastatic attributed to patient's symptomatology and being an uncommon site of involvement for osteopoikilosis and furtherly confirmed by biopsy. /sec suggested to be secondary to ostieitis pubis. Those lesions were not conspicuous neither on conventional MRI nor on bone scan.
B C A B A
The 15 false negative lesions on bone scan were predominantly lytic (11), two of which were aggressive pelvic and vertebral lesions. These lesions were encountered as 7 appendicular, 4 pelvic, 2 vertebral and 2 thoracic. Collectively, we found out that bone scan gave an overall sensitivity of 85.6%, specificity of 67.5%, PPV of 61.7% and NPV of 66.3%. Those findings were partly noted in our study where most of the thoracic lesions (12 out of 15) were seen in breast cancer cases and then 5 of the 8 appendicular lesions delineated on bone scan were in lung cancer cases. As for the WB-MRI study, it was assessed with and without diffusion to verify whether or not it was worth adding an extra 25-30 minutes to the study. WB-MRI without diffusion detected 172 lesions distributed as 82 vertebral, 43 pelvic, 33 appendicular, 10 thoracic and 4 calvarial. Out of these lesions, 112 lesions were confidently reported metastatic with a distribution of 62 vertebral, 26 pelvic, 18 appendicular, 4 thoracic and 2 calvarial. The remaining 60 lesions were considered benign (44 lesions) or equivocal (16 lesions). On adding diffusion, 197 lesions were detected with an extra of 25 lesions. 17 of these extra lesions were of significance proven metastatic (2 by biopsy and 15 by follow up) and 3 other lesions turned out false positive (2 by biopsy and 1 by follow up). The remainder 5 lesions were true negative for metastases. Those lesions were met with in 14 patients. There was another mismatch but this time the lesions were seen on bone scan and not on MRI, they were 20 lesions on WB-MRI without diffusion and came down to 14 lesions on adding DWI. It is worth mentioning that the majority of missed lesions (9) on MRI were in one case having diffusely accentuated red marrow signal attributed to chronic anaemia obscuring the lesions (metastasis was suspected by the reporter, but distinct specific lesions couldn't be verified) as demonstrated in figure (5). 
C B A
After establishment of the diagnosis through biopsy or follow up, on WB-MRI without diffusion 91 lesions were true positive, 18 lesions false positive, 34 lesions true negative, 14 lesions false negative and 16 lesions were equivocal. Then on WB-MRI with diffusion, 119 lesions were true positive, 13 lesions false positive, 41 lesions true negative, 11 lesions false negative and 9 lesions remained equivocal. Bone scan has a higher accuracy for the detection and characterization of vertebral and calvarial lesions while it wouldn't be the modality of choice for appendicular lesions. On the other hand, WB-MRI has a higher accuracy for the detection and characterization of pelvic, appendicular followed by vertebral lesions while it wouldn't be the modality of choice for calvarial lesions. As for thoracic lesions, we found out that DWI improved their detection through 3D MPR and thick stack coronal MIP's. Globally, on comparing sensitivities; bone scan was 85.6%, WB-MRI without diffusion was 73.4% and WB-MRI with diffusion 88.9%. On comparing specificities; bone scan was 67.5%, WB-MRI without diffusion was 68.8% and WB-MRI with diffusion was 82.9%. On comparing PPV's; bone scan was 61.7%, WB-MRI without diffusion was 78.1% and WB-MRI with diffusion was 93%. On comparing NPV's; bone scan was 66.3%, WB-MRI without diffusion was 62.6% and WB-MRI with diffusion 69%. [7] We compared these results with other studies, the majority of which didn't employ diffusion studies and only included STIR and T1W sequences with and without contrast. The first comparative study between whole-body MRI using turbo spin imaging and planar skeletal scintigraphy was carried out in 1997 by Eustace et al. A total of 25 patients with various tumor types were examined. The authors reported 96.5% sensitivity and 100% specificity for whole body MRI. Planar skeletal scintigraphy as the established method had a sensitivity of 72% and a specificity of 98%. [8] Steinborn et al. examined 18 patients with various malignant primary diseases and suspicion of bone metastases with an examination protocol that incorporated STIR imaging and a T1-weighted spinecho sequence. The whole-body MRI detected 91.4% of the metastases that were verified during the course of the disease, whereas skeletal scintigraphy only revealed 85% of lesions. [9] We found out that adding diffusion to conventional MR sequences improved the conspicuity of rib lesions, this was supported in Xian Xu, et al's study that also concluded that DWI had no significant influence on the sensitivity of MRI for calvarial lesions. [10] Despite the statistical values favouring DWI, we have to admit that establishing the diagnosis based on follow up is not a 100% accurate method especially in stationary lesions and regressive lesions without therapy but again the gold standard of histopathological verification is not feasible for all suspected metastatic lesions. By incorporating DWI, our study could be considered a dual study going on parallel to each other comparing MRI as a multiparametric upgraded protocol with Bone scan and at the same time comparing the reproducibility of MRI with and without DWI in the detection of osseous and soft tissue metastases. Assessment of lesions included qualitative assessment of lesions based on signal intensity on ADC maps, the more hypointense the lesion the more suggestive of cellular packing and thus of metastases and quantitative assessment through ADC values. There were variable degrees of overlap in ADC values between the different pathological entities, the ones of significance are those intersecting with metastases, where there is an overlap between the Low ADC values of red marrow and metastasis at the range of 0.61 to 0.69 x10 -3 mm 2 /sec and then between metastasis and other benign pathological marrow entities at the range of 0.9 to 1.03 x 10 -3 mm 2 /sec sparing the midrange of 0.7 to 0.89 where only metastatic lesions gave these values in our study.
Another study showed Mean ADCs of the normal bone marrow, 0.57 ± 0.20 and 0.29 ± 0.15 × 10 -3 mm 2 /s, for red and yellow marrow respectively and a mean ADC value of 0.61 +/-0.21× 10 -3 mm 2 /s for metastatic lesions. [10] Through all the studies -we came acrossthat tackled quantitative assessments of diffusion through ADC values, there was no sole cut off value; each study showed a degree of overlap between normal marrow, benign and malignant lesions. We concluded in our study that a mean range of 0.7 to 0.89 x 10 -3 mm 2 /sec was found in metastatic lesions only but then relying on these values to call for metastases in any patient would be unwise because of the influence of underlying marrow being predominantly yellow or red and the lesion itself being lytic, sclerotic or mixed that could significantly alter these values. Biopsy was accessible in 25 lesions, mainly undergone to verify descripancies between both modalities in lesions that would have an impact on management strategies. Biopsy also played a role in this study to assess reliability of DWI as a sole diagnostic tool with lesions indistinguishable/inconspicuous on conventional MRI and bone scan. The forementioned results are representing one sector of the study which is considered the main sector, but then there is another parallel sector of major influence on patient's management and therapeutic planning which is related to the detection and verification of soft tissue metastatic involvement and comparing results of MRI with and without DWI. DWI was capable of detecting 6 more hepatic lesions. It added two more patients that were not diagnosed with hepatic metastases and thus influencing their therapeutic strategies.
An extra case with an adrenal metastasis was diagnosed only on DWI, this case had no other soft tissue metastatic lesions and so this input was of major importance in management planning. A vast number of studies have assessed the role of DWI in the detection and characterization of hepatic and adrenal lesions. Li et al compared DWI with standard T2W sequence in the detection and characterization of hepatic focal lesions revealing an overall detection rate (averaged for two observers) significantly higher for DW (87.7%) versus T2-weighted (70.1%) imaging (P < .001). FLL characterization was not significantly different between DW (89.1%) and T2-weighted (86.8%) imaging (P = .51). ADCs of malignant FLLs were significantly lower than those of benign FLLs (P < .001). [11] An extra case with metastatic leptomeningeal infiltration in the base of the skull was only detected on DWI adding to patient's metastatic load. This patient showed dramatic disappearance of the leptomeningeal infiltration after 3 months post CTH. The majority of soft tissue lesions were verified on follow up and only the left calf intramuscular lesions, the left renal metastasis and an adrenal metastasis were verified by biopsies. Bone scan played a limited role in detection of soft tissue lesions with only one of the cases showing abnormal skin and soft tissue uptake at both calf regions. Our attempt was to help place guidelines for oncologists in the triaging of cancer patients, as to which imaging modality they would benefit the most sparing them the loss of unnecessary time and money and pointing out choices that would directly influence their management planning and prognosis.
CONCLUSION
We don't think that WB-MRI should replace bone scan in the quest for skeletal metastases. However, we believe that WB-MRI should be the modality of choice when both skeletal and soft tissue metastases are suspected and in the follow up of a known metastatic patients for adequate coverage of both skeletal and soft tissue structures combined with qualitative and quantitative features of DWI helping assess tumors at cellular levels even prior to gross morphological changes verifying response to therapy as early as possible sparing patients precious time from drifting with delayed decision making.
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